Sonnet BioTherapeutics Holdings (SONN)

Sonnet BioTherapeutics Holdings (SONN) Financial Statements


Sonnet BioTherapeutics Holdings Financial Overview

Sonnet BioTherapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-12.913; its P/E ratio is -0.16; Sonnet BioTherapeutics Holdings is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 18.63K$ -10.55K$ 36.85K$ 36.45K$ 37.26K
Gross Profit$ 18.63K$ -10.55K$ 36.85K$ 36.45K$ 37.26K
EBIT$ -1.17M$ -3.72M$ -3.95M$ 5.74M$ -5.54M
EBITDA$ -1.15M$ -3.71M$ -3.93M$ 5.75M$ -5.52M
Net Income Common Stockholders$ -1.17M$ -3.72M$ -3.95M$ 5.74M$ -5.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.00M$ 2.27M$ 7.02M$ 11.40M$ 1.70M
Total Assets$ 5.34M$ 5.43M$ 10.03M$ 13.31M$ 4.94M
Total Debt$ 186.69K$ 203.91K$ 220.63K$ 237.61K$ 238.79K
Net Debt$ -2.81M$ -2.07M$ -6.80M$ -11.16M$ -1.46M
Total Liabilities$ 2.77M$ 5.66M$ 6.62M$ 7.94M$ 8.48M
Stockholders Equity$ 2.57M$ -225.98K$ 3.42M$ 5.37M$ -3.54M
Cash Flow-
Free Cash Flow$ -3.09M$ -4.56M$ -6.17M$ -4.70M$ -5.92M
Operating Cash Flow$ -3.09M$ -4.56M$ -6.17M$ -4.70M$ -5.92M
Investing Cash Flow-$ -170.00K$ -12.00K$ -261.25K-
Financing Cash Flow$ 3.84M$ -17.70K$ 1.81M$ 14.65M$ 4.56M
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

Sonnet BioTherapeutics Holdings Debt to Assets

Sonnet BioTherapeutics Holdings Cash Flow

Sonnet BioTherapeutics Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis